MEDP - Medpace Holdings - Stock Price & Dividends

Medpace Holdings, Inc. is a leading provider of clinical research-based drug and medical device development services, operating across North America, Europe, and Asia. The company's comprehensive suite of services spans the entire clinical development process, from Phase I to Phase IV, covering a broad range of therapeutic areas.

Medpace's clinical development services cater to the pharmaceutical, biotechnology, and medical device industries, offering a tailored approach to meet the unique needs of each client. Their services include development plan design, coordinated central laboratory operations, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, new drug application submissions, and post-marketing clinical support.

In addition to these services, Medpace also provides specialized solutions such as bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. This comprehensive range of services enables clients to streamline their clinical development processes, accelerate timelines, and improve outcomes.

Founded in 1992, Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, and has established itself as a trusted partner for companies seeking to bring innovative treatments and devices to market. With a strong commitment to quality, expertise, and customer satisfaction, Medpace continues to drive innovation in the clinical research industry.

For more information, please visit Medpace's website at https://www.medpace.com.